Cite

HARVARD Citation

    Kerr, D. et al. (2021). Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment. Current opinion in chemical biology. pp. 1-12. [Online]. 
  
Back to record